Skip to main navigation
  • We are
    Spark
    • « Back
    • We are
      Spark
      • Spark Voices
  • Our
    Products
  • Our scientific
    platform & programs
    • « Back
    • Our scientific
      platform & programs
      • About Gene Therapy
  • Patients
    & families
    • « Back
    • Patients
      & families
      • Inherited Retinal Diseases
      • Hemophilia
      • Pompe Disease
  • Healthcare
    professionals
  • Investors
    & media
    • « Back
    • Investors
      & media
      • Media
      • Investors Overview
      • Stock Information
        • Stock Quote & Chart
        • Historical Stock Lookup
      • Analyst Coverage
      • Press Releases
      • Events
      • Investor Presentations
      • Corporate Governance
        • Corporate Compliance
        • Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
      • Financial Information
        • SEC Filings
      • Shareholder Services
        • Investor Contacts
  • Join the
    Spark team

Investor Relations

  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Stock Lookup
  • Analyst Coverage
  • Press Releases
  • Events
  • Investor Presentations
  • Corporate Governance
    • Corporate Compliance
    • Highlights
    • Corporate Management Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Annual Report & Proxy
  • Shareholder Services
    • Investor Contacts
  •  Print Page
  •  RSS Feeds
  •  Email Alerts
  •  IR Contacts

Financial Information

  • SEC Filings
  • Annual Reports

Financial Information

Financial Information

  • SEC Filings
  • Annual Reports

Shareholder Tools

  • RSS Feeds
  • Email Alerts
  • Contact IR

Spark Therapeutics, Inc.
3737 Market Street
Philadelphia, PA 19104
Phone: 1-855-SPARKTX / +1 215-220-9300

© Spark Therapeutics, Inc.

LinkedIn

Twitter

  • Contact us
  • Privacy policy
  • Terms of use